regulanet® is a network of regulatory affairs consultancies with members in over 80 countries throughout the world. Founded in 2001 and led by Dr Regenold GmbH, regulanet® offers services to a wide variety of national and international healthcare and pharmaceutical clients.
The network uses state-of-the–art tools to ensure efficient communication and access to information between members and clients. regulanet® provides advice and assistance on national and international projects and marketing authorisation procedures, including the decentralised, mutual recognition and centralised procedures within Europe.
The core service of regulanet® is regulatory affairs specialising in several product categories from prescription medicines, OTCs, medical devices through to food supplements. Building upon this and in response to client feedback and demand, the services have now been expanded to include Market Access, Portfolio Analysis and Life Cycle Management.
By gaining an understanding of clients’ commercial needs, the key decision makers and route to market, regulanet® is able to recommend regulatory and market access solutions which help clients bring their products efficiently to market and maximise value from their asset.
To learn more about regulanet® and our services have a browse through the website or download our leaflet: